pernicious anemia is treated with injections of vitamin b12 because Raising awareness for anaemia and A patient is newly diagnosed

It is not intended for: Human use Veterinary use Diagnostic use Therapeutic use Clinical administration Safety Profile Safety data for 5-Amino-1MQ is derived primarily from: In vitro research Preclinical animal studies Experimental metabolic pathway investigations Safety outcomes may depend on: Experimental concentration Exposure duration Model system Route of administration in preclinical studies No established safety profile exists for clinical or non-research use

It is intended for use in clinical settings where oral administration is not feasible or where higher plasma concentrations are desired, such as in cases of severe deficiency, certain infections, or as adjunctive therapy in specific medical protocols

This dose is given daily for the first week to quickly fill up body stores

The Company is developing an anti-abdominal obesity botanical drug, ALS-L1023, which is in phase III clinical trial in Korea

AOD9604 is a modified form of the Amino Acid 176-191 of the GH polypeptide